Liminatus Pharma, Inc. (LIMN)

NASDAQ: LIMN · Real-Time Price · USD
7.17
-0.28 (-3.76%)
May 12, 2025, 1:53 PM - Market open
-3.76%
Market Cap 186.52M
Revenue (ttm) n/a
Net Income (ttm) -4.09M
Shares Out 26.01M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 58,867
Open 8.22
Previous Close 7.45
Day's Range 7.17 - 9.40
52-Week Range 6.00 - 9.15
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date n/a

About LIMN

Liminatus Pharma, LLC operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country United States
Stock Exchange NASDAQ
Ticker Symbol LIMN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.